acrolein has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF; Huang, WS; Lee, MM; Leung, YM; Tsai, HY; Wang, YW; Wood, WG | 1 |
| Baker, G; Khan, MA; Moskal, JR; Tanay, VA; Todd, KG; Wood, PL | 1 |
2 other study(ies) available for acrolein and Brain Ischemia
| Article | Year |
|---|---|
Trans-Cinnamaldehyde, An Essential Oil in Cinnamon Powder, Ameliorates Cerebral Ischemia-Induced Brain Injury via Inhibition of Neuroinflammation Through Attenuation of iNOS, COX-2 Expression and NFκ-B Signaling Pathway.
Topics: Acrolein; Animals; Brain Injuries; Brain Ischemia; Cinnamomum zeylanicum; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Inflammation; Microglia; NF-kappa B; Nitric Oxide Synthase Type II | 2016 |
Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine.
Topics: Acrolein; Aldehydes; Animals; Brain; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Gerbillinae; Male; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Phenelzine; Propylamines; Rats; Reperfusion Injury; Retina; Retinal Ganglion Cells; Time Factors | 2006 |